Duke to Act as CRO for ISCO’s Stem Cell Parkinson’s Disease Trial – OutSourcing-Pharma.com
|
Duke to Act as CRO for ISCO’s Stem Cell Parkinson’s Disease Trial
OutSourcing-Pharma.com ISCO’s approach is to transform pathenogenetic neural stem cells (hPNSC) into dopaminergic neurons that express neurotrophic factors like glial derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). These compounds can protect … |
